{"id":"W2719623628","doi":"10.1634/theoncologist.2017-0072","title":"Palbociclib Combined with Fulvestrant in Premenopausal Women with Advanced Breast Cancer and Prior Progression on Endocrine Therapy: PALOMA-3 Results","year":2017,"lang":"en","type":"article","venue":"The Oncologist","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":158,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"Cancer Research UK; AstraZeneca; American Society of Clinical Oncology; Pfizer","keywords":"Palbociclib; Fulvestrant; Medicine; Goserelin; Anastrozole; Internal medicine; Oncology; Breast cancer; Adverse effect; Neutropenia; Placebo; Letrozole; Gynecology; Cancer; Metastatic breast cancer; Chemotherapy; Tamoxifen","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001500879,0.0005833021,0.0009143275,0.0003591115,0.0001834866,0.0007090748,0.0004869152,0.0005282721,0.003638394],"category_scores_gemma":[0.001181295,0.0001801188,0.00141313,0.0004042812,0.0003789963,0.0003849712,0.0003093902,0.001438933,0.0005444766],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007810784,"about_ca_system_score_gemma":0.001093887,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001249122,"about_ca_topic_score_gemma":0.003446594,"domain_scores_codex":[0.9996303,0.0001826142,0.00002385829,0.00005328616,0.00005781659,0.00005215385],"domain_scores_gemma":[0.999385,0.0001804093,0.0001448466,0.00005051592,0.00006566394,0.0001735613],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6127627,0.01629139,0.05150937,0.001689879,0.003912049,0.0005364181,0.0002330746,0.00132454,0.02213828,0.0002142841,0.002979556,0.2864084],"study_design_scores_gemma":[0.2929473,0.4783129,0.1876821,0.0003193922,0.006355416,0.002201917,0.0002026485,0.002147157,0.01319115,0.0004350055,0.01613533,0.00006965712],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9854873,0.009367217,0.0002900179,0.0006994564,0.00006210779,0.0006255565,0.0009611484,0.00004902487,0.002458161],"genre_scores_gemma":[0.994689,0.002234647,0.000381715,0.0004485396,0.00008525405,0.0003089879,0.00106968,0.0000108002,0.0007714904],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003638394,"threshold_uncertainty_score":0.01217163,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02206593019534308,"score_gpt":0.3371386426214998,"score_spread":0.3150727124261567,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}